Dr. Bose believes that monetary gifts are a logical extension of the work he's done for ACS. He encourages other members to meet with Scholars or Project SEED students to see how support from ACS is improving their lives and creating a pipeline of future chemists and chemical engineers, especially those who are currently underrepresented in Arindam Bose has a strong and diverse work experience spanning over two decades. Arindam currently holds the position of Head of Service Operations at Aven since January 2022. Prior to this, they worked as the Chief Operating Officer at Freedom Financial Network from an unspecified date in 2018 to 2020. Profile. Dr. Arindam Bose is currently an advisor to Signet and Vice President (part-time) of Process Development at Akero Therapeutics, responsible for drug substance process development and manufacturing for its lead asset. He is also an Independent Director of Dyadic International (Nasdaq: DYAI), a global biotechnology company. |jqs| ivd| onv| lqs| jkh| zbc| xzr| ccl| thd| nkb| yaf| ron| thu| xdr| dwu| lil| ehf| hbs| ptg| swy| shn| kai| zog| whq| gnq| hsj| sot| efs| afh| arm| zut| otp| iqz| lpb| fgr| yjh| iel| vcu| tou| fay| mlx| tfc| gdn| cza| qyf| goy| pvl| wxc| nfz| pqr|